Purpose To clarify some relevant and significant inconsistencies and inaccuracies in review by Mainini et al. entitled "Imageguided thermal ablation of benign thyroid nodules" published in Journal of Ultrasound to avoid giving incorrect information to the reader and prevent that operators make wrong choices in the use of various devices and technologies available. Results Total cases treated with radiofrequency would be 2388 and not 2435 as reported in Table 1 of this review. The major, minor complications, and side effects in the partial group treated with laser technique and reported in this review are actually 1.2, 3.8, and 35.4%, respectively. In series of patients treated with laser ablation, including a total of 2345 patients, major and minor complications are 0.7 and 1.4%, respectively. The major complications of laser technology are less severe than RFA. Conclusions Several points regarding the paper by Mainini et al. need to be discussed, and I advocate authors for replying to my considerations to clarify the issues raised. Sommario Obiettivo chiarire rilevanti e significative incongruenze e inesattezze nella review di Mainini et al intitolata "Ablazione termica guidata dall'imaging dei noduli benigni tiroidei" pubblicata sul Journal of Ultrasound allo scopo di evitare di fornire informazioni non corrette a chi legge e prevenire che gli operatori facciano scelte errate nell'uso dei vari dispositivi e tecnologie disponibili. Risultati il numero totale dei casi trattati con radiofrequenza dovrebbero essere 2.388 e non 2.435 come riportato nella tabella 1 di questa revisione. Le maggiori e le minori complicanze e gli effetti collaterali nel gruppo parziale trattato con la tecnica laser riportato in questa revisione sono in realtà rispettivamente 1,2%, 3,8% e 35,4%. Nelle serie maggiori di pazienti trattati con la ablazione laser che comprendono un totale di 2345 pazienti, le maggiori e minori complicazioni sono rispettivamente 0,7% e 1,4%. Le complicazioni maggiori della tecnologia laser sono meno severe rispetto alla ablazione con radiofrequenza. Conclusioni alcuni punti che riguardano lo scritto della Mainini, e al. necessitano di essere discussi, e chiedo agli autori di rispondere alle mie considerazioni in maniera da chiarire i problemi emersi.
In accordance with the present trend in the management of thyroid disease that suggests a less aggressive and tailored therapeutic approach also for low-risk thyroid malignancy [1] it seems appropriate to decrease the current use of surgery for definitely benign thyroid lesions. Due to the rather constant rate of growth of enlarging thyroid nodules, an effort should be addressed to change their natural history when they become symptomatic. In light of these considerations, the minimally invasive hyperthermic techniques are increasingly used in daily clinical practice in percutaneous debulking of benign thyroid nodules [2] [3] [4] . These techniques offer several advantages when compared to surgery. These treatment options are low-cost outpatient procedures, do not result in cervical scar nor loss of thyroid function, and are nearly completely devoid of risk of permanent complications [5] . These interesting outcomes obtained in the last decade by various US-guided minimally invasive therapies (MITs) [6] explains the growing flowering of sophisticated studies to verify reliably the benign nature of the nodules before treatment and to monitor the effectivenss of the technique used in inducing volume reduction of the nodules and the amelioration of clinical problems of the patients after the procedure [7] . Among these, quantitative-elastosonography (Q-elastography) and contrast-enhanced ultrasound (CEUS) can offer useful informations both for planning and for subsequently assessing the results. In particular, they can provide pre-and peri-operative additional informations for characterization of nodule to be treated. CEUS is pivotal in assessing the actual extent of the coagulation zone induced immediately after the procedure and during follow-up [8, 9] .
Therefore, I read with interest the paper by Mainini et al. entitled "Image-guided thermal ablation of benign thyroid nodules" published in the Journal of Ultrasound [10] .
We congratulate the authors for their interesting review. However, in our opinion, this paper presents some limitations, as data provided are not based on a systematic review of the available literature. Particularly, data regarding results and complications of laser ablation need some comment and clarification, as they might appear not well balanced in comparison of the latter with the RFA.
As recently reported by Wang et al. in their recent comprehensive systematic review on radiofrequency ablation, there are some major limitations in the present literature regarding the analysis of results and complications of ablations for benign thyroid nodules [11] In particular, the criteria used to define complications and the time sequences are different as the patients came from different centers with their own criteria. Post-RFA thyroid complications are rarely recorded systematically. Even in large thyroid RFA series, complications were either not reported or were mentioned to be limited. The absence of randomized controlled trials and the availability of only two retrospective studies designed to record thyroid RFA complications [12, 13] as the primary aim prevented a meta-analysis from being performed. Moreover, a majority of the articles had an observational design, which precluded the ability to comment on the precise risks and cause of complications. Such results could reflect the inconsistent definitions of complications.
We fully agree with what says Wang and endorse its conclusions. Basically, one of the major problems is the absence of a unanimous consensus on the criteria for classification of major complications, minor complications and side effects, and even if major societies have reported guidelines for complications' classification, they are rarely applied. More generally, we believe it is necessary to plan a conference to find consensus also about the enrollement criteria of patients who may actually benefit from these percutaneous ablative treatments [14] .
What said above is confirmed by what is reported in the paper by Mainini et al.: "Reported major complications of thyroid RF ablation include voice change, nodule rupture, hypothyroidism, and brachial plexus injury; minor complications include hematoma, vomiting, skin burn, pain, edema, fever, or coughing. In most articles, pain is considered as a minor complications only when is persists for more than 2 or 3 days after ablation; otherwise, it is considered as side effect. Pain during the procedure was considered as a complication, not simply as a side effect in only one article [15] ". Finally, tolerable pain immediately after RF ablation was not regarded as a complication or side effect in other article [12] .
In other words, each center uses its own evaluation criteria. With the laser ablation technique four authors used the criteria recommended by of Society of International Radiology [16] [17] [18] [19] , unlike what done by researchers who used the RFA in only one retrospective study [13] .
In light of the above said there is need to clarify some relevant and significant inconsistencies and inaccuracies to avoid giving incorrect information to the reader and prevent that operators make wrong choices in the use of various devices and technologies available:
1. It is unclear how the authors calculated the data in Table 1 In conclusion, several points regarding the paper by Mainini et al. need to be discussed, and I advocate authors replying to my considerations to clarify the issues raised.
Sincerely Claudio M Pacella.
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